Basic Information
Basic information for LINC00343-323-13aa-1
Peptide Name LINC00343-323-13aa-1
Genome Position chr13:105763926-105763964[+]
Species Human
Peptide Sequence MCRCQAIQENHLL
Peptide Length 13
Unique No (LINC00343-202-13aa-3,LINC00343-205-13aa,LINC00343-225-13aa-1,LINC00343-232-13aa-2,LINC00343-243-13aa-2,LINC00343-250-13aa-1,LINC00343-252-13aa-1,LINC00343-253-13aa-1,LINC00343-255-13aa-3,LINC00343-257-13aa-1,LINC00343-258-13aa-2,LINC00343-262-13aa-1,LINC00343-264-13aa-1,LINC00343-265-13aa,LINC00343-270-13aa-1,LINC00343-291-13aa-1,LINC00343-293-13aa-1,LINC00343-294-13aa-3,LINC00343-299-13aa,LINC00343-303-13aa-2,LINC00343-306-13aa,LINC00343-315-13aa-1,LINC00343-321-13aa-1,LINC00343-324-13aa-1,LINC00343-326-13aa-1,LINC00343-328-13aa-3)
Grand Average of Hydropathicity -0.0692
Relative Molecular Mass 1775.04
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000670771;LINC00343-323
Transcript Length 1983
Coding Ability 0.4937
DNA Sequence Corresponding to Peptide ATGTGCAGATGCCAAGCCATCCAAGAAAATCATCTCTTG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :